5 completed. 5 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
| Phase 1 | 1 | Completed 1 |
Follow IPI-926: new trials by email Literature Review of IPI-926 trials Research Report on IPI-926
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas Patidegib, Vehicle gel - Basal Cell Carcinomas | Phase 2 | Completed | PellePharm, Inc. | 36 | 2016-11-11 | 2019-01-08 |
| Trial of Patidegib Gel 2%, 4%, and Vehicle to Decrease the Number of Surgically Eligible Basal Cell Carcinomas in Gorlin Syndrome Patients Patidegib, Vehicle gel - Basal Cell Nevus Syndrome | Phase 2 | Completed | PellePharm, Inc. | 17 | 2016-06-06 | 2020-07-23 |
| A Phase 2 Study With IPI-926 in Patients With Myelofibrosis IPI-926 - Primary Myelofibrosis, Fibrosis, Bone Marrow | Phase 2 | Completed | Infinity Pharmaceuticals, Inc. | 14 | 2011-10-01 | 2012-11-15 |
| A Safety and Efficacy Study of Patients With Metastatic or Locally Advanced (Unresectable) Chondrosarcoma IPI-926, Placebo Arm - Conventional Chondrosarcoma | Phase 2 | Completed | Infinity Pharmaceuticals, Inc. | 105 | 2011-02-01 | 2013-12-05 |
| A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer IPI-926 plus gemcitabine, Placebo plus gemcitabine - Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Completed | Infinity Pharmaceuticals, Inc. | 122 | 2010-04-01 | 2017-03-06 |
Basal Cell Nevus Syndrome (2) · Carcinoma, Basal Cell (2) · Bone Neoplasms (1) · Pancreatic Neoplasms (1) · Primary Myelofibrosis (1)
Infinity Pharmaceuticals, Inc. (3) · PellePharm, Inc. (2)
United States (4) · Canada (2) · United Kingdom (2) · Australia (1) · Austria (1) · France (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1) · Russia (1) · Sweden (1)
Ervin Epstein, MD (1) · John Lear, MD (1) · Pedro Santabarbara, MD (1) · Robert Ross, MD (1) · Srdan Verstovsek, M.D.; Ph.D (1)
2015 (1)